TRK xDFG Mutations Trigger a Sensitivity Switch from Type I to II Kinase Inhibitors is a research paper published in Cancer Discovery (2020). On theSindex it has a DataRank of 0. It has been cited 70 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: T32 CA160001
HHS | NIH | National Cancer Institute
Grant: P30 CA008748
NCI NIH HHS
Grant: R01 CA204749
NIH HHS
Grant: S10 OD023669
NCI NIH HHS
Grant: R01 CA226864
NCI NIH HHS
Grant: R01 CA181746
NCI NIH HHS
Grant: T32 CA009207
National Institutes of Health
Grant: 5T32CA009207-43
Investigational Cancer Therapeutics Training Program
National Institutes of Health
Grant: 2P30CA008748-43
MOUSE GENETICS
National Institutes of Health
Grant: 5R01CA181746-04
Harnessing beneficial off-target effects of kinase inhibitors in lung cancer
National Institutes of Health
Grant: 5R01CA226864-04
Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition
National Institutes of Health
Grant: 5T32CA160001-03
Translational Research in Oncology Training Program
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals